Dolby Laboratories (NYSE:DLB) SVP Sells 7,667 Shares

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of Dolby Laboratories stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $61.05, for a total value of $468,070.35. Following the completion of the transaction, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $7,248,283.35. This trade represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Dolby Laboratories Stock Up 0.3%

NYSE DLB traded up $0.16 on Thursday, hitting $61.95. 777,418 shares of the stock were exchanged, compared to its average volume of 924,476. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $73.78. The company has a 50-day moving average price of $56.41 and a 200-day moving average price of $58.30. The company has a market cap of $5.80 billion, a PE ratio of 26.36 and a beta of 0.80.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.02. The business had revenue of $305.00 million during the quarter, compared to analysts’ expectations of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities research analysts predict that Dolby Laboratories will post 3.23 EPS for the current fiscal year.

Dolby Laboratories declared that its Board of Directors has approved a stock buyback plan on Thursday, July 30th that authorizes the company to repurchase $350.00 million in outstanding shares. This repurchase authorization authorizes the electronics maker to repurchase up to 7% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.

Dolby Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio is 61.28%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on DLB shares. Weiss Ratings lowered Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Friday, August 28th. Barrington Research restated an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $83.00.

Institutional Trading of Dolby Laboratories

Hedge funds have recently made changes to their positions in the company. Fifth Third Bancorp increased its stake in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after acquiring an additional 192 shares during the period. Aquatic Capital Management LLC acquired a new position in Dolby Laboratories during the third quarter worth $56,000. iSAM Funds UK Ltd purchased a new position in Dolby Laboratories in the third quarter worth $68,000. Quarry LP raised its position in Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock worth $76,000 after acquiring an additional 1,115 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in Dolby Laboratories by 48.4% in the fourth quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock valued at $79,000 after acquiring an additional 402 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.